EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.
EnsiliTech has raised $6.1M in total funding. The most recent round was Seed. The last funding was announced in August 2025.
EnsiliTech's investors include Empirical Ventures, Eos, Innovate UK, Elbow Beach Capital, Calculus Capital.
EnsiliTech is headquartered in Bristol, United Kingdom.
EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.
EnsiliTech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnsiliTech — Funding & Investors." VCBacked, August 28, 2025, https://www.vcbacked.co/company/ensilitech. Accessed October 1, 2026.
VCBacked. (2025). EnsiliTech — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/ensilitech
{{cite web |title=EnsiliTech — Funding & Investors |url=https://www.vcbacked.co/company/ensilitech |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated